Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Nov 21 424B4 Prospectus supplement with pricing info
- 5 Nov 21 EFFECT Notice of effectiveness
- 3 Nov 21 F-1/A Registration statement (foreign) (amended)
-
26 Oct 21 F-1 Registration statement (foreign)
EVAX similar filings
- 22 Aug 22 Registration statement (foreign) (amended)
- 7 Jul 22 Registration statement (foreign)
- 3 Nov 21 Registration statement (foreign) (amended)
- 26 Oct 21 Registration statement (foreign)
- 1 Feb 21 Registration statement (foreign) (amended)
- 25 Jan 21 Registration statement (foreign) (amended)
- 19 Jan 21 Registration statement (foreign) (amended)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 7, 2021, in the Registration Statement (Form F-1) and related Prospectus of Evaxion Biotech A/S for the registration of its ordinary shares.
/s/ EY Godkendt Revisionspartnerselskab
Copenhagen, Denmark
October 26, 2021